Current challenges in human embryonic stem cell research: Directed differentiation and transplantation tolerance

Journal of Biological Regulators and Homeostatic Agents

Volumn 18, Issue 3-4, 2004, Pages 347-351

  Ponsaerts, Peter ^a   Van Tendeloo, V F I ^a   Jorens, P G ^b   Berneman, Z N ^a   Van Bockstaele, D R ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Differentiation; Embryonic stem cells; Gene transfer; mRNA electroporation; Tolerance; Transplantation

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; CELL DIFFERENTIATION; CELL TYPE; CLINICAL PROTOCOL; EMBRYONIC STEM CELL; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNER CELL MASS; MEDICAL RESEARCH; NONHUMAN; STEM CELL TRANSPLANTATION; CYTOLOGY; EMBRYO; METABOLISM; REVIEW; STEM CELL; TRANSPLANTATION TOLERANCE;

CELL DIFFERENTIATION; EMBRYO; GENE TRANSFER TECHNIQUES; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION TOLERANCE;

EID: 17844404239     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Webber DJ, Minger SL. Therapeutic potential of stem cells in central nervous system regeneration. Current Opinion in Investigational Drugs 2004; 5: 714-9.
2. Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet 2004; 364: 203-5.
3. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004; 364: 183-92.
4. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000; 18: 399-404.
5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-47.
6. Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 2004; 22: 53-4.
7. Amit M, Margulets V, Segev H, et al. Human feeder layers for human embryonic stem cells. Biology of Reproduction 2003; 68: 2150-6.
8. Richards M, Fong CY, Chan WK, Wong PC, Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002; 20: 933-6.
9. Hovatta O, Mikkola M, Gertow K, et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Human Reproduction 2003; 18: 1404-9.
10. Rosler ES, Fisk GJ, Ares X, et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Developmental Dynamics 2004; 229: 259-74.
11. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001; 19: 971-4.
12. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circulation Research 2003; 93: 32-9.
13. Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Molecular Medicine 2000; 6: 88-95.
14. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108: 407-14.
15. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001; 50: 1691-7.
16. Clark AT, Bodnar MS, Fox M, et al. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Human Molecular Genetics 2004; 13: 727-39.
17. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 4391-6.
18. Lavon N, Yanuka O, Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 2004; 72: 230-8.
19. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation Res 2002; 91: 501-8.
20. Chadwick K, Wang L, Li L, et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003; 102: 906-15.
21. Cerdan C, Rouleau A, Bhatia M. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 2004; 103: 2504-12.
22. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Nat Acad Sci USA 2001; 98: 10716-21.
23. Park S, Lee KS, Lee YJ, et al. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neuroscience Letters 2004; 359: 99-103.
24. Schuldiner M, Eiges R, Eden A, et al. Induced neuronal differentiation of human embryonic stem cells. Brain Res 2001; 913: 201-5.
25. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001; 19: 1129-33.
26. Schulz TC, Palmarini GM, Noggle SA, Weiler DA, Mitalipova MM, Condie BG. Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci 2003; 4: 27.
27. Sottile V, Thomson A, McWhir J. In vitro osteogenic differentiation of human ES cells. Cloning and Stem Cells 2003; 5: 149-55.
28. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003; 12: 1-11.
29. Lakshmipathy U, Pelacho B, Sudo K, et al. Efficient transfection of embryonic and adult stem cells. Stem Cells 2004; 22: 531-43.
30. Smith-Arica JR, Thomson AJ, Ansell R, Chiorini J, Davidson B, McWhir J. Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning and Stem Cells 2003; 5: 51-62.
31. Gropp M, Itsykson P, Singer O, et al. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Molecular Therapy 2003; 7: 281-7.
32. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 2003; 21: 111-7.
33. Ponsaerts P, Van den Bosch G, Cools N, et al. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. J Immunol 2002; 169: 1669-75.
34. Ponsaerts P, Van Tendeloo VF, Cools N, et al. mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia 2002; 16: 1324-30.
35. Van Tendeloo VF, Willems R, Ponsaerts P, et al. High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Therapy 2000; 7: 1431-7.
36. Ponsaerts P, Van Tendeloo VF, Berneman ZN. Cancer immunotherapy using RNA-loaded dendritic cells. Clinical and Experimental Immunology 2003; 134: 378-84.
37. Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature 2002; 418: 252-8.
38. Ponsaerts P, Brown JP, Van Den Plas D, et al. Messenger RNA electroporation is highly efficient in mouse embryonic stem cells: Successful FLPe- and Cre-mediated recombination. Gene Therapy 2004 (in press).
39. Van Den Plas D, Ponsaerts P, Van Tendeloo VFI, Van Bockstaele DR, Berneman ZN, Merregaert J, Efficient removal of LoxP-flanked genes by electroporation of Cre-recombinase mRNA. Biochemical and Biophysical Research Communications 2003; 305: 10-5.
40. Ponsaerts P, Van der Sar S, Van Tendeloo VF, Jorens PG, Berneman ZN, Singh PB. Highly efficient mRNA-based gene transfer in feeder-free cultured H9 human embryonic stem cells. Cloning and Stem Cells 2004; 6: 211-6.
41. Game DS, Lechler RI. Pathways of allorecognition: Implications for transplantation tolerance. Transpl Immunol 2002; 10: 101-8.
42. Smith JM, Nemeth TL, McDonald RA. Current immunosuppressive agents: Efficacy, side effects, and utilization. Pediatric Clinics of North America 2003; 50: 1283-300.
43. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004; 303: 1669-74.
44. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Nat Acad Sci USA 2002; 99: 9864-9.
45. Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003; 21: 319-21.
46. Van Kaer L. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunology and Cell Biology 2004; 82: 315-22.
47. Green AE, Lissina A, Hutchinson SL, et al. Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin. Clin Exp Immunol 2004; 136: 472-82.
48. Green DR, Ferguson TA. The role of Fas ligand in immune privilege. Nature Reviews Molecular Cell Biology 2001; 2: 917-24.
49. Jonuleit H, Adema G, Schmitt E. Immune regulation by regulatory T cells: Implications for transplantation. Transpl Immunol 2008; 11: 267-76.